Allogene Therapeutics, Inc.
SEC Filing List
ALLO CIK: 0001737287
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | Toppan Merrill/FA | 05/15/2026 | |||
| SCHEDULE 13G/A | 05/13/2026 | ||||
| SCHEDULE 13G/A | 05/13/2026 | ||||
| 8-K | Current report filing | Allogene Therapeutics, Inc. | Workiva Inc. Wdesk FA01 /fa | 05/13/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Allogene Therapeutics, Inc. | Workiva Inc. Wdesk FA01 /fa | 05/13/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Allogene Therapeutics, Inc. | Workiva Inc. Wdesk FA01 /fa | 04/30/2026 | |
| DEF 14A | Definitive proxy statements | Allogene Therapeutics, Inc. | Workiva Inc. Wdesk FA01 /fa | 04/30/2026 | |
| ARS | Annual report to security holders | Allogene Therapeutics, Inc. | Workiva Inc. Wdesk FA01 /fa | 04/30/2026 | |
| 4 | Statement of changes in beneficial owner... | Yoshiyama Annie | Allogene Therapeutics, Inc. | 04/23/2026 | |
| SCHEDULE 13G | Cooley LLP /fa | 04/23/2026 | |||
| No record found. | |||||
| Load More | |||||
